XENON PHARMACEUTICALS INC. Earnings Per Share (Basic)
XENON PHARMACEUTICALS INC. (XENE) reported Earnings Per Share (Basic) of -$1.11 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- XENON PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2026-06-30 was -$1.11.
- XENON PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$1.17.
- XENON PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.15.
- XENON PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2025-06-30 was -$1.07.
- XENON PHARMACEUTICALS INC. earnings per share, basic for fiscal 2025 was -$4.36.
- XENON PHARMACEUTICALS INC. earnings per share, basic for fiscal 2024 was -$3.01.
- XENON PHARMACEUTICALS INC. earnings per share, basic for fiscal 2023 was -$2.73.
- XENON PHARMACEUTICALS INC. earnings per share, basic for fiscal 2022 was -$2.06.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.11 10-Q · filed 2026-08-06 | -$2.28 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$1.17 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$4.36 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$1.15 10-Q · filed 2025-11-03 | -$3.05 10-Q · filed 2025-11-03 | ||
| 2025-06-30 | -$1.07 10-Q · filed 2026-08-06 | -$1.90 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | -$0.83 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$3.01 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$0.81 10-Q · filed 2025-11-03 | -$2.17 10-Q · filed 2025-11-03 | ||
| 2024-06-30 | -$0.75 10-Q · filed 2025-08-11 | -$1.36 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$0.62 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.37 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$2.09 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$2.73 10-K · filed 2026-02-26 |
| 2023-09-30 | -$0.73 10-Q · filed 2024-11-12 | -$1.45 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$2.09 10-Q · filed 2024-11-12 | -$2.66 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2023-06-30 | -$0.72 10-Q · filed 2024-08-08 | -$1.36 10-Q · filed 2024-08-08 | -$1.93 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.49 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2023-03-31 | -$0.63 10-Q · filed 2024-05-09 | -$1.20 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.77 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.33 derived: net income ÷ weighted average shares · filed 2025-02-27 |
| 2022-12-31 | -$0.57 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.14 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.69 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.06 10-K · filed 2025-02-27 |
| 2022-09-30 | -$0.57 10-Q · filed 2023-11-08 | -$1.12 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.49 10-Q · filed 2023-11-08 | -$1.96 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2022-06-30 | -$0.55 10-Q · filed 2023-08-09 | -$0.91 10-Q · filed 2023-08-09 | -$1.38 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.76 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2022-03-31 | -$0.35 10-Q · filed 2023-05-09 | -$0.82 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.19 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.69 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2021-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$0.84 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.35 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.77 10-K · filed 2024-02-29 |
| 2021-09-30 | -$0.36 10-Q · filed 2022-11-08 | -$0.87 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.29 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$0.51 10-Q · filed 2022-08-09 | -$0.94 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | -$0.81 10-K · filed 2023-03-01 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | -$0.22 10-Q · filed 2020-08-06 | ||
| 2019-06-30 | -$0.37 10-Q · filed 2020-08-06 | -$0.80 10-Q · filed 2020-08-06 | -$1.12 derived: net income ÷ weighted average shares · filed 2020-08-06 | -$1.71 derived: net income ÷ weighted average shares · filed 2020-08-06 |
| 2019-03-31 | -$0.42 10-Q · filed 2019-05-07 | -$0.75 derived: net income ÷ weighted average shares · filed 2020-05-26 | -$1.34 derived: net income ÷ weighted average shares · filed 2020-05-26 | -$1.79 derived: net income ÷ weighted average shares · filed 2020-05-26 |
| 2018-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$0.92 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$1.37 derived: net income ÷ weighted average shares · filed 2020-03-09 | -$1.63 10-K · filed 2019-03-06 |
| 2018-09-30 | -$0.63 10-Q · filed 2018-11-06 | -$1.11 derived: net income ÷ weighted average shares · filed 2019-11-05 | -$1.34 10-Q · filed 2018-11-06 | -$1.76 derived: net income ÷ weighted average shares · filed 2019-11-05 |
| 2018-06-30 | -$0.45 10-Q · filed 2018-08-07 | -$0.66 10-Q · filed 2018-08-07 | -$1.09 derived: net income ÷ weighted average shares · filed 2019-08-06 | -$1.53 derived: net income ÷ weighted average shares · filed 2019-08-06 |
| 2018-03-31 | -$0.21 10-Q · filed 2019-05-07 | -$0.66 derived: net income ÷ weighted average shares · filed 2019-05-07 | -$1.09 derived: net income ÷ weighted average shares · filed 2019-05-07 | -$1.50 derived: net income ÷ weighted average shares · filed 2019-05-07 |
| 2017-12-31 | -$0.45 10-K · filed 2018-03-07 | -$0.88 derived: net income ÷ weighted average shares · filed 2019-03-06 | -$1.29 derived: net income ÷ weighted average shares · filed 2019-03-06 | -$1.71 10-K · filed 2019-03-06 |
| 2017-09-30 | -$0.43 10-Q · filed 2018-11-06 | -$0.84 derived: net income ÷ weighted average shares · filed 2018-11-06 | -$1.26 10-Q · filed 2018-11-06 | -$1.59 derived: net income ÷ weighted average shares · filed 2018-11-06 |
| 2017-06-30 | -$0.41 10-Q · filed 2018-08-07 | -$0.83 10-Q · filed 2018-08-07 | -$1.16 derived: net income ÷ weighted average shares · filed 2018-08-07 | -$1.66 derived: net income ÷ weighted average shares · filed 2018-08-07 |
| 2017-03-31 | -$0.42 10-Q · filed 2018-05-08 | -$0.75 derived: net income ÷ weighted average shares · filed 2018-05-08 | -$1.25 derived: net income ÷ weighted average shares · filed 2018-05-08 | -$1.66 derived: net income ÷ weighted average shares · filed 2018-05-08 |
| 2016-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$0.83 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.24 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.48 10-K · filed 2018-03-07 |
| 2016-09-30 | -$0.51 10-Q · filed 2017-11-07 | -$0.93 derived: net income ÷ weighted average shares · filed 2017-11-07 | -$1.16 10-Q · filed 2017-11-07 | -$1.43 derived: net income ÷ weighted average shares · filed 2018-03-07 |
| 2016-06-30 | -$0.42 10-Q · filed 2017-08-03 | -$0.64 10-Q · filed 2017-08-03 | -$0.92 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.19 derived: net income ÷ weighted average shares · filed 2018-03-07 |
| 2016-03-31 | -$0.23 10-Q · filed 2017-05-09 | -$0.50 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$0.77 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$0.69 derived: net income ÷ weighted average shares · filed 2018-03-07 |
| 2015-12-31 | -$0.27 10-K · filed 2017-03-08 | -$0.54 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$0.46 derived: net income ÷ weighted average shares · filed 2018-03-07 | -$1.10 10-K · filed 2018-03-07 |
| 2015-09-30 | -$0.27 10-K · filed 2017-03-08 | -$0.19 derived: net income ÷ weighted average shares · filed 2016-08-03 | -$0.83 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $0.08 10-K · filed 2017-03-08 | -$0.56 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | -$0.64 10-K · filed 2017-03-08 | |||
| 2014-12-31 | $0.14 10-K · filed 2016-03-08 | $0.97 derived: net income ÷ weighted average shares · filed 2017-03-08 | $1.28 derived: net income ÷ weighted average shares · filed 2017-03-08 | $4.11 10-K · filed 2017-03-08 |
| 2014-09-30 | $2.67 10-K · filed 2016-03-08 | $2.67 derived: net income ÷ weighted average shares · filed 2016-03-08 | $2.67 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $0.00 derived: net income ÷ weighted average shares · filed 2015-08-13 | $0.00 derived: net income ÷ weighted average shares · filed 2015-08-13 | ||
| 2013-12-31 | $1.87 10-K · filed 2015-03-12 | $2.86 derived: net income ÷ weighted average shares · filed 2016-03-08 | $2.87 10-K · filed 2016-03-08 | |
| 2013-09-30 | $0.99 10-K · filed 2015-03-12 | $0.99 10-Q · filed 2014-12-15 | ||
| 2012-12-31 | -$3.24 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |